|
|
Article: Other News To Note.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
o Aastrom Biosciences Inc., of Ann Arbor, Mich., said its wholly owned subsidiary, Zellera AG, entered an agreement with Mathys Medical Ltd., of Bettlach, Switzerland, to begin a trial using Aastrom's Tissue Repair Cells with Mathys' commercial synthetic bone graft matrix for bone graft applications. The trial, which is expected to accrue five to 10 patients with serious tibia fractures, will be conducted at the Bergmannsheil University Clinic in Bochum, Germany.
o Acacia Research Corp., of Newport Beach, Calif., said CombiMatrix designed and fabricated a microarray based on the SARS (severe acute respiratory syndrome) coronavirus genome published earlier this ...